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Intestinal-Cell Kinase and Juvenile Myoclonic Epilepsy
To the Editor: With regard to the article by Bai-
ley et al. (March 15, 2018, issue)1 on the potential 
role of variants in the gene encoding intestinal-
cell kinase (ICK) in genetic generalized epilepsies, 
including juvenile myoclonic epilepsy: We attempt-
ed replication by rechecking for enrichment of 
ICK variants in two previously published analyses 
of mainly familial cases of genetic generalized 
epilepsy,2,3 which included a total of 1149 cases of 
genetic generalized epilepsy and 5911 ethnically 
matched controls. We analyzed the burden of 
single-gene rare variants with the use of whole-
exome sequencing data, applying population 
stratification and both sample and variant qual-
ity control. We found no evidence of an enrich-
ment of ICK variants in genetic generalized epilep-
sies or juvenile myoclonic epilepsy. Specifically, 
we did not detect a nonsynonymous variant in 
357 persons with juvenile myoclonic epilepsy at a 
minor allele frequency at or below 0.1%. Although 
we cannot exclude the possibility that ICK vari-
ants may be population-specific risk factors for 
juvenile myoclonic epilepsy, the lack of validation 
in our cohorts does not support a true disease 
association but rather suggests that the authors’ 
results may be due to chance, possibly owing to 
methodologic issues (see the Supplementary Ap-
pendix, available with the full text of this letter at 
NEJM.org).
Holger Lerche, M.D. 
Samuel F. Berkovic, M.D. 
Daniel H. Lowenstein, M.D.
University of Tübingen 
Tübingen, Germany 
holger . lerche@ uni-tuebingen . de
for the EuroEPINOMICS-CoGIE, 
EpiPGX, Epi4K, EPGP Consortia
No potential conflict of interest relevant to this letter was re-
ported.
1. Bailey JN, de Nijs L, Bai D, et al. Variant intestinal-cell kinase 
in juvenile myoclonic epilepsy. N Engl J Med 2018; 378: 1018-28.
2. Epi4K Consortium, Epilepsy Phenome/Genome Project. Ultra-
rare genetic variation in common epilepsies: a case-control se-
quencing study. Lancet Neurol 2017; 16: 135-43.
3. May P, Girard S, Harrer M, et al. Rare coding variants in 
genes encoding GABAA receptors in genetic generalised epilep-
sies: an exome-based case-control study. Lancet Neurol 2018; 17: 
699-708.
DOI: 10.1056/NEJMc1805100
The authors reply: We thank Lerche et al. for 
sharing their data and respectfully disagree with 
their suggestion that the association between 
variant ICK and juvenile myoclonic epilepsy that 
we described is due to chance, given our reliance 
on guidelines from the National Human Genome 
Research Institute in establishing causality of 
sequence variants.1 We also applied guidelines 
from the American College of Medical Genetics 
and Genomics and the Association for Molecular 
Pathology (ACMG–AMP) when we weighed and 
scored evidence for the pathogenicity of ICK vari-
ants, although we acknowledge that the ACMG–
AMP guidelines were formulated, in the main, to 
determine the pathogenicity of new variants in 
genes previously established as pathogenic when 
variant. However, the multiple lines of evidence 
that we obtained contributed to inferences at the 
level of both variant and gene1,2 and thus impli-
cate ICK variants as pathogenic in persons with 
juvenile myoclonic epilepsy from Latin America 
and Japan.1
There is overwhelming evidence that both 
locus and allelic heterogeneity is high in epi-
lepsy. In our view, this is the most likely explana-
tion for the negative findings in the European and 
North American data sets cited by Lerche et al.
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